TET Enzymes in the Immune system: from DNA demethylation to immunotherapy, inflammation, and cancer

IF López-Moyado, M Ko, PG Hogan… - Annual Review of …, 2024 - annualreviews.org
Ten-eleven translocation (TET) proteins are iron-dependent and α-ketoglutarate-dependent
dioxygenases that sequentially oxidize the methyl group of 5-methylcytosine (5mC) to 5 …

Insect-pathogen crosstalk and the cellular-molecular mechanisms of insect immunity: uncovering the underlying signaling pathways and immune regulatory function of …

DK Mahanta, TK Bhoi, J Komal, I Samal… - Frontiers in …, 2023 - frontiersin.org
Multicellular organisms are constantly subjected to pathogens that might be harmful.
Although insects lack an adaptive immune system, they possess highly effective anti …

Rare variant associations with plasma protein levels in the UK Biobank

RS Dhindsa, OS Burren, BB Sun, BP Prins, D Matelska… - Nature, 2023 - nature.com
Integrating human genomics and proteomics can help elucidate disease mechanisms,
identify clinical biomarkers and discover drug targets,,–. Because previous proteogenomic …

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy

MP Hamilton, T Sugio, T Noordenbos… - … England Journal of …, 2024 - Mass Medical Soc
Background The risk of second tumors after chimeric antigen receptor (CAR) T-cell therapy,
especially the risk of T-cell neoplasms related to viral vector integration, is an emerging …

Ultraviolet radiation shapes dendritic cell leukaemia transformation in the skin

GK Griffin, CAG Booth, K Togami, SS Chung, D Ssozi… - Nature, 2023 - nature.com
Tumours most often arise from progression of precursor clones within a single anatomical
niche. In the bone marrow, clonal progenitors can undergo malignant transformation to …

Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy

TG Kang, X Lan, T Mi, H Chen, S Alli, SE Lim… - Science, 2024 - science.org
Epigenetic reinforcement of T cell exhaustion is known to be a major barrier limiting T cell
responses during immunotherapy. However, the core epigenetic regulators restricting …

NLRP3 and cancer: Pathogenesis and therapeutic opportunities

IW Tengesdal, CA Dinarello, C Marchetti - Pharmacology & Therapeutics, 2023 - Elsevier
More than a decade ago IL-1 blockade was suggested as an add-on therapy for the
treatment of cancer. This proposal was based on the overall safety record of anti-IL-1 …

Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene–Environment Interactions

C Cobaleda, LA Godley, KE Nichols, MW Wlodarski… - Cancer discovery, 2024 - AACR
The recognition of host genetic factors underlying susceptibility to hematopoietic
malignancies has increased greatly over the last decade. Historically, germline …

Long-term longitudinal analysis of 4,187 participants reveals insights into determinants of clonal hematopoiesis

MM Uddin, S Saadatagah, A Niroula, B Yu… - Nature …, 2024 - nature.com
Clonal hematopoiesis of indeterminate potential (CHIP) is linked to diverse aging-related
diseases, including hematologic malignancy and atherosclerotic cardiovascular disease …

Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies

IE Stergiou, C Tsironis, SP Papadakos… - International Journal of …, 2024 - mdpi.com
Inflammasomes are multimeric protein complexes, sensors of intracellular danger signals,
and crucial components of the innate immune system, with the NLRP3 inflammasome being …